Skip to content

Clinical trials

Completed Phase 1/2 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Completed Country / region: Japan Clear all

167 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20035
20042
20056
20063
20076
20088
20095
20104
20116
20129
20139
201415
201514
20169
201714
20185
20198
202012
202113
20224
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed167

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Takeda8
AstraZeneca7
Bristol-Myers Squibb7
Eli Lilly and Company5
Pfizer5
Tokyo University4
Amgen3
AnGes, Inc.3
Chiba University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular9
Carcinoma, Non-Small-Cell Lung9
COVID-197
Stomach Neoplasms7
Colorectal Neoplasms6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Neoplasm Metastasis6
Breast Neoplasms5
Esophageal Neoplasms5
Neoplasms5

Trials

Showing 1 to 25 of 167. Each trial links to its page on Pharma Observatory.

67 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.